NY-ESO-1 ISCOMATRIX
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NY-ESO-1 ISCOMATRIX, covering 2017-06-23 to 2021-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma [Phase 2]